The dexamethasone suppression test in patients with mood disorders

被引:127
作者
Rush, AJ
Giles, DE
Schlesser, MA
Orsulak, PJ
Parker, CR
Weissenburger, JE
Crowley, GT
Khatami, M
Vasavada, N
机构
[1] UNIV TEXAS, SW MED CTR, MENTAL HLTH CLIN RES CTR, DALLAS, TX 75235 USA
[2] UNIV ROCHESTER, MED CTR, DEPT PSYCHIAT & NEUROL, ROCHESTER, NY 14642 USA
[3] DALLAS NEUROPSYCHIAT ASSOCIATES, DALLAS, TX USA
[4] DEPT VET AFFAIRS MED CTR, DALLAS, TX USA
[5] UNIV ALABAMA, SCH MED, DEPT OBSTET & GYNECOL, BIRMINGHAM, AL USA
[6] DEPT VET AFFAIRS MED CTR, SAN ANTONIO, TX USA
关键词
D O I
10.4088/JCP.v57n1006
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Background: This study was undertaken to (1) determine whether the endogenous/nonendogenous mood disorder dichotomy is validated by the dexamethasone suppression test (DST); (2) determine whether other subtyping schemes (unipolar/bipolar, DSM-III melancholic/nonmelancholic, Winokur's family history subtypes) relate to the DST; (3) evaluate the relative contributions of symptom severity, weight loss, and other factors to DST status; and (4) assess the relative sensitivity of various post-dexamethasone cortisol determinations in the detection of dexamethasone nonsuppression. Method: 487 consecutive adult inpatients (N = 131) and outpatients (N = 356) with unipolar (N = 422) or bipolar disorder (N = 65) underwent the 1.0-mg DST. Nonsuppression was defined as at least one post-dexamethasone cortisol measurement > 4.0 mu g/dL. Results: Nonsuppression occurred in 27% of all patients with major depression and 43% of all bipolar depressed phase patients. For outpatients, dexamethasone nonsuppression occurred in 35.2% of subjects with endogenous (unipolar + bipolar; N = 145) and 9.0% of those with nonendogenous (unipolar only; N = 211) depressions (single 4 p.m. post-dexamethasone cortisol). For inpatients, dexamethasone nonsuppression was found in 61.5% of subjects with endogenous (N = 104) and 18.5% of those with nonendogenous (N = 27) depressions (three post-dexamethasone cortisol determinations). For the inpatient and outpatient sample together, the DST had a sensitivity of 46.2% and a specificity of 89.9% in differentiating endogenous from nonendogenous major depressive episodes. Weight loss, gender, and symptom severity added little to the endogenous/nonendogenous dichotomy. The Research Diagnostic Criteria (RDC) primary/secondary and Winokur and colleagues' family history subtypes for unipolar depression were not strongly validated by the DST. The 4 p.m. and 11 p.m. samples together detected 91.0% of those inpatients with abnormal three-sample DST results. The 8 a.m. sample alone detected 30% of those, the 4 p.m. sample alone detected 67%, and the 11 p.m. sample alone detected 62%. Conclusion: The RDC endogenous/nonendogenous dichotomy was validated by the DST.
引用
收藏
页码:470 / 484
页数:15
相关论文
共 159 条
[1]   PATTERNS OF DEPRESSION REFLECTED IN PITUITARY THYROID AND PITUITARY-ADRENAL ENDOCRINE CHANGES [J].
AGREN, H ;
WIDE, L .
PSYCHONEUROENDOCRINOLOGY, 1982, 7 (04) :309-327
[2]   STUDY OF THE DIAGNOSTIC-VALUE OF THE DEXAMETHASONE SUPPRESSION TEST IN ENDOGENOUS-DEPRESSION [J].
AGUILAR, MT ;
LEMAIRE, M ;
CASTRO, P ;
LIBOTTE, M ;
REYNDERS, J ;
HERCHUELZ, A .
JOURNAL OF AFFECTIVE DISORDERS, 1984, 6 (01) :33-42
[3]   A STUDY OF THE DEXAMETHASONE SUPPRESSION TEST IN HOSPITALIZED DEPRESSED-PATIENTS [J].
AMES, D ;
BURROWS, G ;
DAVIES, B ;
MAGUIRE, K ;
NORMAN, T .
BRITISH JOURNAL OF PSYCHIATRY, 1984, 144 (MAR) :311-313
[4]  
AMSTERDAM JD, 1982, AM J PSYCHIAT, V139, P287
[5]  
ANDREASEN NC, 1977, ARCH GEN PSYCHIAT, V34, P1229
[6]  
[Anonymous], 1997, INT CLASSIFICATION D
[7]  
[Anonymous], 1980, DSM 3
[8]  
ARANA GW, 1985, ARCH GEN PSYCHIAT, V42, P1193
[9]  
ARANA GW, 1983, AM J PSYCHIAT, V140, P1521
[10]   THE DEXAMETHASONE SUPPRESSION TEST IN DEPRESSIVE-ILLNESS - CLINICAL CORRELATES [J].
ASNIS, GM ;
HALBREICH, U ;
NATHAN, RS ;
OSTROW, L ;
NOVACENKO, H ;
ENDICOTT, J ;
SACHAR, EJ .
PSYCHONEUROENDOCRINOLOGY, 1982, 7 (04) :295-301